Table 2.

Comparison of Preferences in Attributes of a New Point-of-Care Test for Sexually Transmitted Infections between Clinician and Industry Survey Participants.

2A: Rank of Attributes
Ranking	Clinician Survey	Industry Survey
A. Overall	n=218	n=107
1^st	Sensitivity	Sensitivity
2^nd	Cost ^a	Specificity ^a
3^rd	Specificity ^a	Time ^a
4^th	Time ^a	Cost ^a
B. Chlamydia as Priority	n=136	n=42
1^st	Sensitivity	Sensitivity
2^nd	Cost ^a	Specificity ^a
3^rd	Specificity ^a	Cost ^a
4^th	Time	Time
C. HIV Seroconversion as Priority	n=30	n=34
1^st	Sensitivity	Sensitivity
2^nd	Specificity	Specificity
3^rd	Cost ^a	Cost ^a
4^th	Time ^a	Time ^a

2B: Preferred Level of Value of Attributes ^b
Attributes	Clinician Survey	Industry Survey
A. Overall	n=218	n=107
Sensitivity	90–99%	90–99%
Specificity	99%	99%
Cost	$20 ^c	$35 ^c
Time	5 min	5 min
B. Chlamydia as Priority	n=136	n=42
Sensitivity	90–99%	90–99%
Specificity	99% ^c	95% ^c
Cost	$20 ^c	$35 ^c
Time	5 min ^c	15 min ^c
C. HIV Seroconversion as Priority	n=30	n=34
Sensitivity	90–99%	90–99%
Specificity	99%	99%
Cost	$35	$35
Time	15 min ^c	25 min ^c

Difference in ranking of attributes between clinicians and industry participants

Values of attributes investigated in this study included 3 levels of sensitivity (70–79%, 80–89%, $90%), 3 levels of specificity (90%, 95%, 99%), 3 levels of turn-around time (5 minutes, 15 minutes, 25 minutes), and 3 levels of cost ($20, $35, $50).

Difference in preferred level of value of attributes between clinicians and industry participants